Press release
Pharmaceutical Drug Development Sector Market Set for Explosive Growth | Catalent, Takeda Pharmaceutical, Novartis, GlaxoSmithKline
The “ Pharmaceutical Drug Development Sector Scorecard, Q3 2021 - Market Development Scenario ” Study has been added to HTF MI database. The study covers in-depth overview, description about the Product, Industry Scope and elaborates market outlook and growth status to 2027. At present, the market is developing its presence following current economic slowdown and its Impact. Some of the key players considered in the study are Takeda Pharmaceutical Co Ltd, Merck & Co Inc, AstraZeneca Plc, Bristol-Myers Squibb Co, Pfizer Inc, Johnson & Johnson, Boehringer Ingelheim, Parexel International Corp, F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline Plc, Bayer AG, Eli Lilly and Co, IQVIA Holdings Inc, AbbVie Inc, Merck KGaA, Novo Nordisk AS, Catalent Inc, Gilead Sciences Inc, Thermo Fisher Scientific Inc, Astellas, Biogen Inc, Cipla Ltd, Lonza Group Ltd, Amgen Inc, Daiichi Sankyo Co Ltd, Vertex Pharmaceuticals Inc, WuXi AppTec Co Ltd, Charles River Laboratories International Inc, CSL Ltd, Reliance Life Sciences Pvt Ltd, Sanofi, Innovent Biologics Inc, Otsuka, Teva Pharmaceutical Industries Ltd, UCB, Dr. Reddy's Laboratories Ltd, Regeneron Pharmaceuticals Inc, Samsung Bioepis Co Ltd, Sun Pharmaceutical Industries Ltd, Biocad, Cadila Pharmaceuticals Ltd, Celltrion Inc, Coherus BioSciences Inc, CSPC Pharmaceutical Group Ltd, Generium, Intas Pharmaceuticals Ltd, Lupin Ltd, Perrigo Co Plc, Pharmaceutical Product Development LLC, Seagen Inc, Shanghai Henlius Biotech Inc, Viatris Inc, Zydus Cadila.Access sample report @ https://www.htfmarketreport.com/sample-report/3657872-pharmaceutical-drug-development-sector-scorecard-q3-2021-update-thematic-research
Summary
AI was one of the most dynamic technology themes for pharma in 2021, with companies forging additional strategic partnerships with AI vendors, particularly in drug development, as well as participating in funding rounds for AI start-ups. Several big pharma companies saw their AI scores increase from 4 to 5, including Bristol Myers Squibb (BMS), AstraZeneca, and Johnson and Johnson (J&J), mainly due to additional strategic partnerships and funding activity with AI vendors. BMS also announced in August 2021 that it had secured a license to an immune-modulating drug candidate created by Exscientia.
Other areas of drug development that had significant activity in 2021 include immuno-oncology and genomics, highlighting that despite the pressures that COVID-19 placed on the pharma industry, companies are still investing in innovative areas of R&D. There were several mergers and acquisitions (M&A) in immuno-oncology and genomics in 2021, including the acquisition of Five Prime Therapeutics and TeneoBio by Amgen, and Translate Bio by Sanofi.
Microbiome-related activity by big pharma has been relatively quiet in recent years, but Takeda announced in August 2021 that it was to progress a new candidate into Phase I trials in 2022. One of the most important score decreases was for Astellas in regenerative medicine, following the death of a trial participant for its gene therapy AT132. Our thematic scoring methodology is designed to identify tomorrow’s leaders rather than today’s incumbents, based on their competitive position in the 10 most important themes impacting the landscape.
Purchase Single User License of this report @ https://www.htfmarketreport.com/buy-now?format=1&report=3657872
Scope
-Drug Development Thematic Scorecard report provides a top-down, comprehensive future outlook for key players in the drug development sector over the next two to four years.
- These themes are Virtual Care, Rare Disease, Orphan Designated Drugs, Strategic Alliances, Real-world Evidence, AI, ESG, Cybersecurity, Cloud Computing, and Blockchain.
- The scorecard includes 54 companies from across the industry, including biopharmaceutical companies, biosimilar and generic manufacturers, contract development and manufacturing organizations (CDMOs), and contract research organizations (CROs).
- The methodology contains detailed information on what data sources were used to generate the thematic scores for each company.
Reasons to Buy
- Identify the key clinical trial themes for the next 2-4 years and learn how they will impact the market.
- Understand which key themes should be addressed to drive share price.
- Understand which companies are best positioned for success within critical themes and why.
- Learn which companies have underinvested in key themes and are most vulnerable to disruption.
- Help companies adapt their strategy to anticipate and benefit from these themes as they play out.
- Help identify future winners and losers in drug development to inform partnership strategies.
Companies Mentioned in the Report
Takeda Pharmaceutical Co Ltd
Merck & Co Inc
AstraZeneca Plc
Bristol-Myers Squibb Co
Pfizer Inc
Johnson & Johnson
Boehringer Ingelheim
Parexel International Corp
F. Hoffmann-La Roche Ltd
Novartis AG
GlaxoSmithKline Plc
Bayer AG
Eli Lilly and Co
IQVIA Holdings Inc
AbbVie Inc
Merck KGaA
Novo Nordisk AS
Catalent Inc
Gilead Sciences Inc
Thermo Fisher Scientific Inc
Astellas
Biogen Inc
Cipla Ltd
Lonza Group Ltd
Amgen Inc
Daiichi Sankyo Co Ltd
Vertex Pharmaceuticals Inc
WuXi AppTec Co Ltd
Charles River Laboratories International Inc
CSL Ltd
Reliance Life Sciences Pvt Ltd
Sanofi
Innovent Biologics Inc
Otsuka
Teva Pharmaceutical Industries Ltd
UCB
Dr. Reddy's Laboratories Ltd
Regeneron Pharmaceuticals Inc
Samsung Bioepis Co Ltd
Sun Pharmaceutical Industries Ltd
Biocad
Cadila Pharmaceuticals Ltd
Celltrion Inc
Coherus BioSciences Inc
CSPC Pharmaceutical Group Ltd
Generium
Intas Pharmaceuticals Ltd
Lupin Ltd
Perrigo Co Plc
Pharmaceutical Product Development LLC
Seagen Inc
Shanghai Henlius Biotech Inc
Viatris Inc
Zydus Cadila
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/3657872-pharmaceutical-drug-development-sector-scorecard-q3-2021-update-thematic-research
Table of Contents
Executive Summary
Introduction
Pharma Theme Map
Drug Development Scorecard
Company Screen
Thematic Screen
Valuation Screen
Our Thematic Research Methodology
....Continued
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/3657872-pharmaceutical-drug-development-sector-scorecard-q3-2021-update-thematic-research
It's vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
HTF Market Intelligence consulting is uniquely positioned empower and inspire with research and consulting services to empower businesses with growth strategies, by offering services with extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist in decision making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmaceutical Drug Development Sector Market Set for Explosive Growth | Catalent, Takeda Pharmaceutical, Novartis, GlaxoSmithKline here
News-ID: 2448449 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
![Photovoltaic Solar Charge Controller Sales Market May See Big Move |Morningstar Corporation, OutBack Power Technologies](https://cdn.open-pr.com/L/9/L908376793_g.jpg)
Photovoltaic Solar Charge Controller Sales Market May See Big Move |Morningstar …
According to HTF Market Intelligence, the Global Photovoltaic Solar Charge Controller Sales market to witness a CAGR of 15.5% during the forecast period (2024-2030). The Latest Released Photovoltaic Solar Charge Controller Sales Market Research assesses the future growth potential of the Photovoltaic Solar Charge Controller Sales market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers…
![Fast Fashion Market is Set To Fly High in Years to Come|Authentic Brands Group , Cotton On](https://cdn.open-pr.com/L/9/L908331237_g.jpg)
Fast Fashion Market is Set To Fly High in Years to Come|Authentic Brands Group , …
According to HTF Market Intelligence, the Global Fast Fashion market to witness a CAGR of 14.56% during the forecast period (2024-2030). The Latest Released Fast Fashion Market Research assesses the future growth potential of the Fast Fashion market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
![Zinc Flake Market to See Huge Growth by 2030:Shishengst, Aalberts NV](https://cdn.open-pr.com/L/9/L908658350_g.jpg)
Zinc Flake Market to See Huge Growth by 2030:Shishengst, Aalberts NV
According to HTF Market Intelligence, the Global Zinc Flake market to witness a CAGR of 4.37% during the forecast period (2024-2030). The Latest Released Zinc Flake Market Research assesses the future growth potential of the Zinc Flake market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
![Caffeine-based Drinks Market Is Booming Worldwide |Red Bull,Keurig Dr Pepper](https://cdn.open-pr.com/L/9/L908437324_g.jpg)
Caffeine-based Drinks Market Is Booming Worldwide |Red Bull,Keurig Dr Pepper
According to HTF Market Intelligence, the Global Caffeine-based Drinks market to witness a CAGR of 7.00% during the forecast period (2024-2030). The Latest Released Caffeine-based Drinks Market Research assesses the future growth potential of the Caffeine-based Drinks market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
More Releases for Pharma
Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors.
Access the PDF sample of the report@…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period.
For More Info, Get Sample Report…
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide…
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986
Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications…